Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yu-Shen Orbits Technology is a biotechnology company specializing in the development of advanced microfluidic systems for liquid biopsy and cell analysis. The company's flagship Orbits platform enables the high-purity isolation and characterization of rare cells, such as circulating tumor cells (CTCs), from blood samples. By providing high-throughput and automated solutions, Yu-Shen Orbits supports clinical research in oncology, enabling better monitoring of disease progression and treatment response. Their technology is designed to bridge the gap between complex laboratory assays and routine clinical diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yu-Shen Orbits Technology Company.